30 September 2014

This application note demonstrates the feasibility of using BioBLU 5c single-use vessels for the production of clinical dose-scale numbers of MSCs. The study also validates the general applicability of the CelliGen BLU benchtop bioreactor and BioBLU single-use vessels for large-scale process optimization and production of stem cells in numbers appropriate for clinical applications in regenerative medicine.